|
US4576957A
(en)
*
|
1984-07-05 |
1986-03-18 |
American Cyanamid Company |
N-(Substituted phenyl)-N'-[(1H-imidazol-1-yl) and (1H-1,2,4-triazol-1-yl)alkyl]ureas
|
|
US5017584A
(en)
*
|
1984-12-20 |
1991-05-21 |
Sterling Drug Inc. |
Antidepressant 2-(4,5-dihydro-1H-imidazolyl)-dihydro-1H-indoles, -1,2,3,4-tetrahydroquinolines and -1H-indoles, and methods of use thereas
|
|
US4902505A
(en)
*
|
1986-07-30 |
1990-02-20 |
Alkermes |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
|
IT1222563B
(it)
*
|
1986-09-30 |
1990-09-05 |
Brasil Compressores Sa |
Compressore ermetico ad albero a gomiti orizzontale
|
|
US5004697A
(en)
*
|
1987-08-17 |
1991-04-02 |
Univ. Of Ca |
Cationized antibodies for delivery through the blood-brain barrier
|
|
US4933324A
(en)
*
|
1988-02-26 |
1990-06-12 |
Shashoua Victor E |
Fatty acid-neuroactive drug conjugate as a prodrug
|
|
US5527527A
(en)
*
|
1989-09-07 |
1996-06-18 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
|
|
US5112596A
(en)
*
|
1990-04-23 |
1992-05-12 |
Alkermes, Inc. |
Method for increasing blood-brain barrier permeability by administering a bradykinin agonist of blood-brain barrier permeability
|
|
US5185248A
(en)
*
|
1990-05-08 |
1993-02-09 |
E. R. Squibb & Sons, Inc. |
Farnesyl-protein transferase assay for identifying compounds that block neoplastic transformation
|
|
US5633376A
(en)
*
|
1990-12-28 |
1997-05-27 |
Neurogen Corporation |
Certain aminomethyl phenylimidazole derivatives; and 4-aryl substituted piperazinyl and piperidinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype ligands
|
|
US5614560A
(en)
*
|
1991-04-04 |
1997-03-25 |
Children's Medical Center Corporation |
Method of preventing NMDA receptor-mediated neuronal damage
|
|
US5322950A
(en)
*
|
1991-12-05 |
1994-06-21 |
Warner-Lambert Company |
Imidazole with angiotensin II antagonist properties
|
|
GB2267966A
(en)
*
|
1992-06-17 |
1993-12-22 |
Merck & Co Inc |
A fluorescence assay for farnesyl protein transferase activity
|
|
US5726197A
(en)
*
|
1992-11-02 |
1998-03-10 |
Syntex (U.S.A.) Inc. |
Isoindolinyl derivatives
|
|
US5523317A
(en)
*
|
1993-07-05 |
1996-06-04 |
Nippon Chemiphar Co., Ltd. |
Method of reducing blood pressure
|
|
US6365588B1
(en)
*
|
1993-10-15 |
2002-04-02 |
Schering Corporation |
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
|
US5719148A
(en)
*
|
1993-10-15 |
1998-02-17 |
Schering Corporation |
Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
|
|
US5576437A
(en)
*
|
1993-12-17 |
1996-11-19 |
The Procter & Gamble Company |
7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists
|
|
HU217841B
(hu)
*
|
1993-12-17 |
2000-04-28 |
The Procter & Gamble Co. |
6-[(2-Imidazolidinilidén)-amino]-kinolin-származékok és ezeket tartalmazó gyógyszerkészítmények
|
|
US5616601A
(en)
*
|
1994-07-28 |
1997-04-01 |
Gd Searle & Co |
1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
|
|
US5856326A
(en)
*
|
1995-03-29 |
1999-01-05 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
GB9515975D0
(en)
*
|
1995-08-04 |
1995-10-04 |
Zeneca Ltd |
Chemical compounds
|
|
DE69620445T2
(de)
*
|
1995-12-08 |
2002-12-12 |
Janssen Pharmaceutica N.V., Beerse |
(imidazol-5-yl)methyl-2-chinolinoderivate als farnesyl protein transferase inhibitoren
|
|
US5874442A
(en)
*
|
1995-12-22 |
1999-02-23 |
Schering-Plough Corporation |
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
|
|
US6011029A
(en)
*
|
1996-02-26 |
2000-01-04 |
Bristol-Myers Squibb Company |
Inhibitors of farnesyl protein transferase
|
|
US5859012A
(en)
*
|
1996-04-03 |
1999-01-12 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
TW436484B
(en)
*
|
1996-04-24 |
2001-05-28 |
Dev Center Biotechnology |
1,2,3,4-tetrahydroisoquinoline derivatives having a nitrogen-containing heterocyclic methyl substituent, the preparation process and pharmaceutical composition thereof
|
|
FR2757855B1
(fr)
*
|
1996-12-30 |
1999-01-29 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
US6013662A
(en)
*
|
1996-12-30 |
2000-01-11 |
Rhone-Poulenc Rorer S.A. |
Farnesyl transferase inhibitors, their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments
|
|
TW591030B
(en)
*
|
1997-03-10 |
2004-06-11 |
Janssen Pharmaceutica Nv |
Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
|
|
RU2205831C2
(ru)
*
|
1997-04-25 |
2003-06-10 |
Янссен Фармацевтика Н.В. |
Хиназолиноны, ингибирующие фарнезилтрансферазу
|
|
US6060038A
(en)
*
|
1997-05-15 |
2000-05-09 |
Merck & Co., Inc. |
Radiolabeled farnesyl-protein transferase inhibitors
|
|
CN100525766C
(zh)
*
|
1997-06-02 |
2009-08-12 |
詹森药业有限公司 |
用作平滑肌细胞增殖抑制剂的（咪唑-5-基）甲基-2-喹啉酮衍生物
|
|
US6358968B1
(en)
*
|
1997-06-17 |
2002-03-19 |
Schering Corporation |
N-substituted urea inhibitors of farnesyl-protein transferase
|
|
TW527355B
(en)
*
|
1997-07-02 |
2003-04-11 |
Bristol Myers Squibb Co |
Inhibitors of farnesyl protein transferase
|
|
US6387903B1
(en)
*
|
1997-08-27 |
2002-05-14 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
WO1999026657A1
(en)
*
|
1997-11-25 |
1999-06-03 |
Musc Foundation For Research Development |
Inhibitors of nitric oxide synthase
|
|
JP2001527078A
(ja)
*
|
1997-12-23 |
2001-12-25 |
アベンテイス・フアルマ・ソシエテ・アノニム |
新規なファルネシルトランスフェラーゼインヒビター、それらの製造、それらを含有する製薬学的組成物及び医薬品の製造のためのそれらの使用
|
|
EP1054925B1
(en)
*
|
1998-02-03 |
2011-10-12 |
Graham Packaging PET Technologies Inc. |
Enhanced oxygen-scavenging polymers, and packaging made therefrom
|
|
JP2002519428A
(ja)
*
|
1998-07-02 |
2002-07-02 |
メルク エンド カムパニー インコーポレーテッド |
プレニル−タンパク質トランスフェラーゼの阻害剤
|
|
PL193464B1
(pl)
*
|
1998-07-06 |
2007-02-28 |
Janssen Pharmaceutica Nv |
Zastosowanie inhibitora białkowej transferazy farnezylowej
|
|
HRP20000904A2
(en)
*
|
1998-07-06 |
2001-12-31 |
Janssen Pharmaceutica Nv |
Farnesyl protein transferase inhibitors for treating arthropathies
|
|
US6338092B1
(en)
*
|
1998-09-24 |
2002-01-08 |
International Business Machines Corporation |
Method, system and computer program for replicating data in a distributed computed environment
|
|
US20020064142A1
(en)
*
|
1998-10-13 |
2002-05-30 |
Franklin P. Antonio |
Base station architecture
|
|
SK11002001A3
(sk)
*
|
1999-02-11 |
2002-05-09 |
Pfizer Products Inc. |
Heteroarylom substituované chinolin-2-ónové deriváty použiteľné ako protinádorové prostriedky
|
|
US6328988B1
(en)
*
|
1999-04-23 |
2001-12-11 |
Rutgers, The State University Of New Jersey |
Hyperbranched polymeric micelles for encapsulation and delivery of hydrophobic molecules
|
|
SI1255537T1
(sl)
*
|
2000-02-04 |
2006-10-31 |
Janssen Pharmaceutica Nv |
Inhibitorji farnezil protein transferaze za zdravljenje raka dojk
|
|
US20020052380A1
(en)
*
|
2000-02-18 |
2002-05-02 |
Dinsmore Christopher J. |
Inhibitors of prenyl-protein transferase
|
|
US20020010184A1
(en)
*
|
2000-02-18 |
2002-01-24 |
Dinsmore Christopher J. |
Inhibitors of prenyl-protein transferase
|
|
ATE375794T1
(de)
*
|
2000-02-24 |
2007-11-15 |
Janssen Pharmaceutica Nv |
Dosierschema enthaldend farnesyl protein transferase inhibitoren für die behandlung von krebs
|
|
JP2003525244A
(ja)
*
|
2000-02-29 |
2003-08-26 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
抗腫瘍性アルキル化剤とのファルネシルタンパク質トランスフェラーゼ阻害剤組み合わせ剤
|
|
EP1261341A2
(en)
*
|
2000-02-29 |
2002-12-04 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with camptothecin compounds
|
|
JP2003525245A
(ja)
*
|
2000-02-29 |
2003-08-26 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ファルネシルタンパク質トランスフェラーゼ阻害剤組み合わせ剤
|
|
AU2001254672A1
(en)
*
|
2000-02-29 |
2001-09-12 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with an her2 antibody
|
|
US20030027808A1
(en)
*
|
2000-02-29 |
2003-02-06 |
Palmer Peter Albert |
Farnesyl protein transferase inhibitor combinations with platinum compounds
|
|
EP1311272B1
(en)
*
|
2000-03-03 |
2006-11-22 |
Eisai Co., Ltd. |
Novel methods using cholinesterase inhibitors
|
|
TWI310684B
(en)
*
|
2000-03-27 |
2009-06-11 |
Bristol Myers Squibb Co |
Synergistic pharmaceutical kits for treating cancer
|
|
US20010051642A1
(en)
*
|
2000-04-17 |
2001-12-13 |
Kyunghye Ahn |
Method for treating Alzheimer's disease
|
|
US6844357B2
(en)
*
|
2000-05-01 |
2005-01-18 |
Pfizer Inc. |
Substituted quinolin-2-one derivatives useful as antiproliferative agents
|
|
ES2310556T3
(es)
*
|
2000-06-23 |
2009-01-16 |
Invista Technologies S.A.R.L. |
Maquina de hilar que comprende una hilera con un anillo de distribucion de vapor.
|
|
CA2417149C
(en)
*
|
2000-07-27 |
2009-09-08 |
City Technology Limited |
Gas sensors
|
|
JP4974437B2
(ja)
*
|
2000-09-25 |
2012-07-11 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ファルネシルトランスフェラーゼを阻害する６−［（置換フェニル）メチル］−キノリンおよびキナゾリン誘導体
|
|
WO2002024686A2
(en)
*
|
2000-09-25 |
2002-03-28 |
Janssen Pharmaceutica N.V. |
Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
|
|
DE60118225T2
(de)
*
|
2000-09-25 |
2007-05-03 |
Janssen Pharmaceutica N.V. |
Chinolin- und chinazolinderivate und deren verwendung als farnesyl transferase inhibitoren
|
|
GB0023915D0
(en)
*
|
2000-09-29 |
2000-11-15 |
Inst Of Ophthalmology |
Treatment of neuroinflammatory disease
|
|
DE60118953T2
(de)
*
|
2000-11-28 |
2007-01-11 |
Janssen Pharmaceutica N.V. |
Farnesyl-protein-transferasehemmer zur behandlung der entzündlichen darmerkrankung
|
|
CA2632091C
(en)
*
|
2000-12-19 |
2011-03-22 |
Pfizer Products Inc. |
Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]-4-(3-ethynyl-phenyl)-1-methyl-1h-quinolin-2-one, 2,3-dihydroxybutanedioate salts and method of production
|
|
AU2002236813A1
(en)
*
|
2001-01-22 |
2002-07-30 |
Schering Corporation |
Treatment of malaria with farnesyl protein transferase inhibitors
|
|
BRPI0208075B8
(pt)
*
|
2001-03-12 |
2021-05-25 |
Janssen Pharmaceutica Nv |
processo para a preparação de compostos de imidazol
|
|
WO2002072085A1
(en)
*
|
2001-03-14 |
2002-09-19 |
Bristol-Myers Squibb Company |
Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
|
|
US20020151563A1
(en)
*
|
2001-03-29 |
2002-10-17 |
Pfizer Inc. |
Farnesyl transferase inhibitors in combination with HMG CoA reductase inhibitors for the inhibition of abnormal cell growth
|
|
AU2002257114A1
(en)
*
|
2001-04-06 |
2002-10-21 |
Schering Corporation |
Treatment of malaria with farsenyl protein transferase inhibitors
|
|
US6939564B2
(en)
*
|
2001-06-08 |
2005-09-06 |
Labopharm, Inc. |
Water-soluble stabilized self-assembled polyelectrolytes
|
|
US6740757B2
(en)
*
|
2001-08-29 |
2004-05-25 |
Pfizer Inc |
Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1h-quinolin-2-one and salts thereof, useful in the treatment of cancer
|
|
AU2002346644A1
(en)
*
|
2001-12-03 |
2003-06-17 |
Schering Corporation |
Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer
|
|
CA2469204A1
(en)
*
|
2001-12-07 |
2003-06-19 |
Regents Of The University Of Michigan |
Prospective identification and characterization of breast cancer stem cells
|
|
AU2003202570A1
(en)
*
|
2002-01-18 |
2003-07-30 |
Lonza Ag |
Virucidal disinfectant
|
|
US6837693B2
(en)
*
|
2002-01-31 |
2005-01-04 |
Ashear, Ltd. |
Fluid-pumping system employing piston-driven pump and employing at least one pulsation dampener
|
|
US6974818B2
(en)
*
|
2002-03-01 |
2005-12-13 |
Euro-Celtique S.A. |
1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain
|
|
US20030050323A1
(en)
*
|
2002-08-28 |
2003-03-13 |
Rybak Mary Ellen Margaret |
Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives
|
|
US20030060480A1
(en)
*
|
2002-08-28 |
2003-03-27 |
Horak Ivan David |
Farnesyl protein transferase inhibitor combinations with vinca alkaloids
|
|
US7082558B2
(en)
*
|
2002-11-25 |
2006-07-25 |
Texas Instruments Incorporated |
Increasing possible test patterns which can be used with sequential scanning techniques to perform speed analysis
|
|
UA81790C2
(uk)
*
|
2002-12-19 |
2008-02-11 |
Фармация Италия С.П.А. |
Заміщені піролопіразольні похідні як інгібітори кінази
|
|
US20070054886A1
(en)
*
|
2003-05-23 |
2007-03-08 |
Ramot At Tel Aviv University, Ltd. |
Ras antagonists for treating neurodegenerative disorders
|
|
US20050089502A1
(en)
*
|
2003-08-21 |
2005-04-28 |
Todd Schansberg |
Effervescent delivery system
|
|
PT1663281E
(pt)
*
|
2003-08-29 |
2014-03-17 |
Dyax Corp |
Inibidores de proteases poli-peguilados
|
|
EP1626339B1
(en)
*
|
2004-08-13 |
2016-02-24 |
Sap Se |
Data processing system and method for assigning objects to processing units
|
|
JPWO2006006730A1
(ja)
*
|
2004-07-15 |
2008-05-01 |
株式会社ニコン |
平面モータ装置、ステージ装置、露光装置及びデバイスの製造方法
|
|
SG155222A1
(en)
*
|
2004-08-13 |
2009-09-30 |
Genentech Inc |
Thiazole based inhibitors of atp-utilizing enzymes
|
|
ES2403060T3
(es)
*
|
2004-11-05 |
2013-05-13 |
Janssen Pharmaceutica Nv |
Uso terapéutico de inhibidores de la farnesiltransferasa y métodos de control de la eficacia de los mismos.
|
|
US20080002621A1
(en)
*
|
2006-06-29 |
2008-01-03 |
Boris Ginzburg |
Reliable multicast techniques for wireless links
|
|
US20090036275A1
(en)
*
|
2007-07-31 |
2009-02-05 |
Chi-Chang Hsiao |
Power-Supplying and Shock-Absorbing Device for an Exerciser
|